Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer

•Exploring application of natural Delonix regia gum as a mucoadhesive polymer.•Nose to brain delivery of ondansetron HCl through nanostructured lipid carriers.•Particle size was observed in the narrow range of 92.28–135nm.•Significantly higher DTE [506%] and DTP [97.14%] values for selected batch (F...

Full description

Saved in:
Bibliographic Details
Published inColloids and surfaces, B, Biointerfaces Vol. 122; pp. 143 - 150
Main Authors Devkar, Tejas B., Tekade, Avinash R., Khandelwal, Kishanchandra R.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.10.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•Exploring application of natural Delonix regia gum as a mucoadhesive polymer.•Nose to brain delivery of ondansetron HCl through nanostructured lipid carriers.•Particle size was observed in the narrow range of 92.28–135nm.•Significantly higher DTE [506%] and DTP [97.14%] values for selected batch (F11). The objective of this investigation was to fabricate ondansetron hydrochloride [OND] loaded mucoadhesive nanostructured lipid carriers [NLCs] for efficient delivery to brain through nasal route. Mucoadhesive NLCs thereby sustaining drug release for longer time in nasal cavity. NLCs were prepared by high pressure homogenization [HPH] technique using glycerol monostearate [GMS]; as solid lipid, Capryol 90; as liquid lipid, soya lecithin; as surfactant and poloxamer 188; as cosurfactant. In the fabrication of NLCs, Delonix regia gum [DRG], isolated from seeds of D. regia belonging to family fabiaceae was used as a mucoadhesive polymer. The NLCs were evaluated for particle size, morphology, drug-entrapment efficiency [%EE], mucoadhesive strength, in vitro drug release, histological examination, ex vivo permeation study, in vivo biodistribution and pharmacokinetic studies in the brain/blood following intravenous [i.v.] and intranasal [i.n.] administration. Particle size, PDI, Zeta potential was observed in the range of 92.28–135nm, 0.32–0.46, and −11.5 to −36.2 respectively. Prepared NLCs achieved thermodynamic stability, control release pattern with minor histopathological changes in sheep nasal mucosa. The significantly [P<0.05] higher values for selected batch was observed, when administered by i.n. route showed higher drug targeting efficiency [506%] and direct transport percentage [97.14%] which confirms the development of promising OND-loaded NLC for efficient nose-to-brain delivery.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0927-7765
1873-4367
DOI:10.1016/j.colsurfb.2014.06.037